Cataract Extraction Clinical Trial
Official title:
Evaluation of the Aspheric ReSTOR IOL After Routine Cataract Extraction
The purpose of this study is to evaluate the visual outcomes and patient satisfaction after bilateral implantation of the aspheric ReSTOR multifocal intraocular lens (IOL) and compare it to a historical control group of patients implanted bilaterally with the spherical ReSTOR multifocal IOL.
Status | Completed |
Enrollment | 20 |
Est. completion date | September 2008 |
Est. primary completion date | |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 40 Years to 80 Years |
Eligibility |
Inclusion Criteria: - Subjects MUST fulfill the following conditions to qualify for enrollment into the trial - Subject must have an age-related cataract in both eyes. - 40 years of age or older. - Patient must desire cataract extraction. - Expected maximum of 2 weeks and minimum of 1-week interval between first and second eye surgeries. - Willing and able to comply with scheduled visits and other study procedures. Exclusion Criteria: - Preoperative ocular pathology: - Amblyopia - Rubella cataract - Proliferative diabetic retinopathy - Shallow anterior chamber - Macular edema - Retinal detachment - Aniridia or iris atrophy - Uveitis - History of iritis - Iris neovascularization - Medically uncontrolled glaucoma - Microphthalmus or macrophthalmus - Optic nerve atrophy - Macular degeneration (with anticipated best postoperative visual acuity less than 20/30) - Advanced glaucomatous damage, etc. - Keratometric astigmatism exceeding 1.50 diopters. - Planned postoperative refraction for mono-vision. - Uncontrolled diabetes. - Use of any systemic or topical drug known to interfere with visual performance. - Contact lens use during the active treatment portion of the trial. - Any concurrent infectious/non infectious conjunctivitis, keratitis or uveitis. - Pregnant or nursing mothers and females of childbearing potential not practicing a reliable and medically acceptable method of birth control. - Any clinically significant, serious or severe medical or psychiatric condition that may increase the risk associated with study participation or study device - implantation or may interfere with the interpretation of study results. - Participation in (or current participation) any investigational drug or device trial within the previous 30 days prior to the start date of this trial. - Intraocular conventional surgery within the past three months or intraocular laser surgery within one month in the operated eye. - Other ocular surgery at the time of the cataract extraction. |
Observational Model: Case Control, Time Perspective: Retrospective
Country | Name | City | State |
---|---|---|---|
United States | Medical University of South Carolina | Charleston | South Carolina |
Lead Sponsor | Collaborator |
---|---|
Medical University of South Carolina |
United States,
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT00924729 -
Study of Ocular Penetration of Topically Administered Fluoroquinolones
|
Phase 4 | |
Completed |
NCT00524264 -
A Study of Ketorolac for the Treatment of Inflammation and Pain Associated With Cataract Surgery
|
Phase 3 | |
Completed |
NCT00521456 -
A Study of Ketorolac for the Treatment of Inflammation and Pain Associated With Cataract Surgery
|
Phase 3 | |
Completed |
NCT02973880 -
Clinical Study to Evaluate the Efficacy and Tolerability of an Anti-inflammatory/Antibiotic Treatment Following Ocular Cataract Extraction
|
Phase 3 | |
Completed |
NCT00721695 -
Exploratory Study of OMS302 Injection in Subjects Undergoing Unilateral Cataract Extraction by Phacoemulsification.
|
Phase 1/Phase 2 | |
Withdrawn |
NCT00466908 -
Accuracy of the Pentacam and IOL Master to Calculate the Effective Corneal Power After Corneal Refractive Surgery
|
||
Completed |
NCT00366665 -
Comparison of the Performance of the Infiniti Vision and the Series 20000 Legacy Phacoemulsification Systems
|
N/A | |
Completed |
NCT05571683 -
Cerebral Oxymeter and End Tidal Carbondioxide Values Under Surgical Drapes With and Without Past COVID-19 Infection
|
||
Not yet recruiting |
NCT04977115 -
Clinical Evaluation of Intraocular Caliper-assisted Capsulotomy for Age-related Cataract
|
N/A | |
Withdrawn |
NCT00366613 -
Clinical Evaluation of the Use of Sealed Capsule Irrigation With Sodium Chloride During Pediatric Cataract Surgery and IOL Implantation
|
Phase 4 | |
Completed |
NCT00366496 -
Surgical Outcomes After Routine Cataract Extraction & Implantation of a Conventional or Spheric Intraocular Lens
|
N/A | |
Not yet recruiting |
NCT03828500 -
Preoperative Fasting for Ambulatory Cataract Surgery: The PRACTICE Study
|
N/A | |
Completed |
NCT00840580 -
Effect on Wound Healing of Vigamox Versus Cravit
|
Phase 4 | |
Completed |
NCT00842231 -
Assessment of Visual Performance in Patients With Low Levels of Astigmatism
|
N/A | |
Completed |
NCT00851760 -
Epiretinal Macular Membrane and Cataract Extraction
|
N/A | |
Recruiting |
NCT03944070 -
Management of Patients With Neovascular Age-related Macular Degeneration Undergoing Cataract Surgery
|
N/A | |
Completed |
NCT03364972 -
A Study Comparing Two Monofocal, Aspheric, Hydrophobic Acrylic Intraocular Lenses: the Alcon CLAREON® and the Abbott Medical Optics PCB00
|
N/A | |
Completed |
NCT00824070 -
Assessment of the Concentrations of Besifloxacin, Moxifloxacin, or Gatifloxacin in the Aqueous Humor of Subjects
|
Phase 1 | |
Completed |
NCT00366691 -
Comparison of Acular LS With Lotemax to Prevent Inflammation After Cataract Surgery and Intraocular Lens Implantation
|
Phase 4 | |
Completed |
NCT00366405 -
Comparison of the Torsional Handpiece to Conventional Handpiece During Routine Phacoemulsification
|
Phase 4 |